Deerland Probiotics & Enzymes Hires Vice President of Sales-Americas, Expands Executive Team

KENNESAW, GA (November 18, 2020) – Deerland Probiotics and Enzymes has announced the hiring of a new vice president of sales-Americas as well as the creation of a new executive level position for product development and supply chain.

Michelle Cook has been named the company’s vice president of sales for the Americas region. Cook brings more than 25 years of experience leading sales teams in the OTC pharmaceutical and dietary supplement industries, most recently with DuPont Nutrition & Biosciences. She will oversee Deerland’s team of business development managers as they serve customers across the dietary supplement, food and beverage and pet nutrition industries.

With the addition of Michelle Cook as vice president of sales, Tod Burgess, who previously held the position for more than 20 years, has moved into the newly created role of vice president of product development and supply chain.  In this role, Burgess’s expertise will be harnessed to optimize the up-front product development process and supply chain continuity.

Scott Ravech, CEO, comments, “The addition of Michelle Cook to our staff along with Tod’s new role as vice president of product development and supply chain position demonstrates Deerland’s commitment to placing the best people in critical roles in order to provide maximum value for our customers.”

Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology.  The company offers a line of unique, clinically validated branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast®, Glutalytic® and Bifolac® probiotic strains.  Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement, food and beverage, sports nutrition, and companion animal markets. In addition to branded ingredients and customized formulations, Deerland offers full turnkey products for private label through its YourBrand® portfolio.  The company’s manufacturing services include bulk blends, capsules, stick packs and tablets, as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.deerland.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

data-driven tools
Leverage Data-Driven Tools and Local SEO for Maximum Search Engine Rankings
July 26, 2024

As businesses continue to navigate the digital landscape, data-driven tools are more crucial than ever for effective SEO strategies. Understanding and implementing the proper SEO practices can make a significant difference with evolving algorithms and competitive markets. Given that 75% of users never scroll past the first page of search results, this statistic underscores…

Read More
On-device AI
On-Device AI is Today’s Tech Innovation, Competition and Market Leadership Driver
July 26, 2024

On-device AI revolutionizes the tech landscape, making it a critical factor for industry dominance. This cutting-edge technology directly integrates advanced AI capabilities into devices, transforming consumer and enterprise applications. This shift stems from the need for improved performance, reduced latency, enhanced data privacy & security, and personalized user experiences. With advancements in neural processing…

Read More
modern supply chains
The Role of AI in Modern Supply Chains: Insights from Aaron Hatfield at Arvist
July 26, 2024

Artificial intelligence rapidly transforms modern supply chains, with companies like Arvist leading the charge. In a recent episode of Hammer Down, hosted by Mike Bush, Aaron Hatfield, the Head of Sales at Arvist, sheds light on AI’s practical applications and benefits in enhancing supply chain operations. Is AI in the supply chain a double-edged…

Read More
semiconductor manufacturing
Training New Semiconductor Manufacturing Professionals is Key to Meet Coming Domestic Manufacturing Demand
July 26, 2024

Over the past few years, the U.S. has made significant strides in semiconductor manufacturing, driven by substantial investments and strategic policies. With the CHIPS Act expected to triple domestic semiconductor manufacturing capacity by 2032, the need for a skilled workforce is more urgent than ever. This discussion explores the key question: What does the…

Read More